Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LT Vaccine Patch for Travelers' Diarrhea
NCT00751777Phase 2Completed
- Sponsor
- Intercell AG
- Start
- Sep 2008
- Primary completion
- Nov 2009
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of travellers' diarrhoea vaccine patch in traveler's diarrhea (TD), sponsored by Intercell AG. Primary endpoints: Geometric Mean Titer at Day 194, Geometric Mean Fold Ratio at Day 194 and 1 more. Started Sep 2008; status: completed.
02
Drugs
travellers' diarrhoea vaccine patch
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT00751777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751777.